Columnar Cell Lesion and Apocrine Hyperplasia of the Breast: Is There a Common Origin? the Role of Prolactin-induced Protein

Amedeo Sciarra, Gianluca Lopez, Chiara Corti, Letterio Runza, Giulia Ercoli, Arturo Bonometti, Luca Despini, Concetta Blundo, Donatella Gambini, Nicola Fusco

Research output: Contribution to journalArticle

Abstract

Noninvasive breast lesions encompass a heterogeneous group of risk indicators and nonobligate precursors of breast cancer, such as apocrine hyperplasia (AH) and columnar cell lesions (CCLs). Given the different expression of ER and ER-regulated genes in AH and CCL, these two alterations are currently considered discrete conditions. However, whether they share early biologic changes is not clear to date. Here, we sought to define the clinicopathologic and immunohistochemical features of a prospective series of combined lesions made up by CCLs and AH forming a continuum within single terminal duct-lobular units. The study group included 19 cases, whereas 25 cases of synchronous contiguous CCLs and AH served as control group. The different components of each case were subjected to immunohistochemical analysis for ER, PR, AR, HER2, BCL2, CCND1, MUC1, and PIP. Although CCLs and AHs arising in continuity showed opposite patterns of ER expression, the PIP-positive apocrine signature was consistently present in both components. In conclusion, apocrine changes are highly recurrent in CCLs growing within foci of AH, regardless of the ER activation. Our results suggest that PIP-positive and PIP-negative CCLs are likely to represent biologically distinct conditions and that apocrine changes might occur earlier than ER activation in the natural history of breast precursor lesions.

Original languageEnglish
Pages (from-to)508-514
Number of pages7
JournalApplied Immunohistochemistry and Molecular Morphology
Volume27
Issue number7
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Prolactin
Hyperplasia
Breast
Proteins
Natural History
Breast Neoplasms
Control Groups
Genes

Keywords

  • apocrine hyperplasia
  • breast
  • columnar cell lesion
  • fibrocystic changes
  • GCDFP15
  • immunohistochemistry
  • PIP

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Medical Laboratory Technology

Cite this

Columnar Cell Lesion and Apocrine Hyperplasia of the Breast : Is There a Common Origin? the Role of Prolactin-induced Protein. / Sciarra, Amedeo; Lopez, Gianluca; Corti, Chiara; Runza, Letterio; Ercoli, Giulia; Bonometti, Arturo; Despini, Luca; Blundo, Concetta; Gambini, Donatella; Fusco, Nicola.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 27, No. 7, 01.08.2019, p. 508-514.

Research output: Contribution to journalArticle

@article{e28d2a113b924eeb8584d98ea3ad402c,
title = "Columnar Cell Lesion and Apocrine Hyperplasia of the Breast: Is There a Common Origin? the Role of Prolactin-induced Protein",
abstract = "Noninvasive breast lesions encompass a heterogeneous group of risk indicators and nonobligate precursors of breast cancer, such as apocrine hyperplasia (AH) and columnar cell lesions (CCLs). Given the different expression of ER and ER-regulated genes in AH and CCL, these two alterations are currently considered discrete conditions. However, whether they share early biologic changes is not clear to date. Here, we sought to define the clinicopathologic and immunohistochemical features of a prospective series of combined lesions made up by CCLs and AH forming a continuum within single terminal duct-lobular units. The study group included 19 cases, whereas 25 cases of synchronous contiguous CCLs and AH served as control group. The different components of each case were subjected to immunohistochemical analysis for ER, PR, AR, HER2, BCL2, CCND1, MUC1, and PIP. Although CCLs and AHs arising in continuity showed opposite patterns of ER expression, the PIP-positive apocrine signature was consistently present in both components. In conclusion, apocrine changes are highly recurrent in CCLs growing within foci of AH, regardless of the ER activation. Our results suggest that PIP-positive and PIP-negative CCLs are likely to represent biologically distinct conditions and that apocrine changes might occur earlier than ER activation in the natural history of breast precursor lesions.",
keywords = "apocrine hyperplasia, breast, columnar cell lesion, fibrocystic changes, GCDFP15, immunohistochemistry, PIP",
author = "Amedeo Sciarra and Gianluca Lopez and Chiara Corti and Letterio Runza and Giulia Ercoli and Arturo Bonometti and Luca Despini and Concetta Blundo and Donatella Gambini and Nicola Fusco",
year = "2019",
month = "8",
day = "1",
doi = "10.1097/PAI.0000000000000604",
language = "English",
volume = "27",
pages = "508--514",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Columnar Cell Lesion and Apocrine Hyperplasia of the Breast

T2 - Is There a Common Origin? the Role of Prolactin-induced Protein

AU - Sciarra, Amedeo

AU - Lopez, Gianluca

AU - Corti, Chiara

AU - Runza, Letterio

AU - Ercoli, Giulia

AU - Bonometti, Arturo

AU - Despini, Luca

AU - Blundo, Concetta

AU - Gambini, Donatella

AU - Fusco, Nicola

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Noninvasive breast lesions encompass a heterogeneous group of risk indicators and nonobligate precursors of breast cancer, such as apocrine hyperplasia (AH) and columnar cell lesions (CCLs). Given the different expression of ER and ER-regulated genes in AH and CCL, these two alterations are currently considered discrete conditions. However, whether they share early biologic changes is not clear to date. Here, we sought to define the clinicopathologic and immunohistochemical features of a prospective series of combined lesions made up by CCLs and AH forming a continuum within single terminal duct-lobular units. The study group included 19 cases, whereas 25 cases of synchronous contiguous CCLs and AH served as control group. The different components of each case were subjected to immunohistochemical analysis for ER, PR, AR, HER2, BCL2, CCND1, MUC1, and PIP. Although CCLs and AHs arising in continuity showed opposite patterns of ER expression, the PIP-positive apocrine signature was consistently present in both components. In conclusion, apocrine changes are highly recurrent in CCLs growing within foci of AH, regardless of the ER activation. Our results suggest that PIP-positive and PIP-negative CCLs are likely to represent biologically distinct conditions and that apocrine changes might occur earlier than ER activation in the natural history of breast precursor lesions.

AB - Noninvasive breast lesions encompass a heterogeneous group of risk indicators and nonobligate precursors of breast cancer, such as apocrine hyperplasia (AH) and columnar cell lesions (CCLs). Given the different expression of ER and ER-regulated genes in AH and CCL, these two alterations are currently considered discrete conditions. However, whether they share early biologic changes is not clear to date. Here, we sought to define the clinicopathologic and immunohistochemical features of a prospective series of combined lesions made up by CCLs and AH forming a continuum within single terminal duct-lobular units. The study group included 19 cases, whereas 25 cases of synchronous contiguous CCLs and AH served as control group. The different components of each case were subjected to immunohistochemical analysis for ER, PR, AR, HER2, BCL2, CCND1, MUC1, and PIP. Although CCLs and AHs arising in continuity showed opposite patterns of ER expression, the PIP-positive apocrine signature was consistently present in both components. In conclusion, apocrine changes are highly recurrent in CCLs growing within foci of AH, regardless of the ER activation. Our results suggest that PIP-positive and PIP-negative CCLs are likely to represent biologically distinct conditions and that apocrine changes might occur earlier than ER activation in the natural history of breast precursor lesions.

KW - apocrine hyperplasia

KW - breast

KW - columnar cell lesion

KW - fibrocystic changes

KW - GCDFP15

KW - immunohistochemistry

KW - PIP

UR - http://www.scopus.com/inward/record.url?scp=85071268352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071268352&partnerID=8YFLogxK

U2 - 10.1097/PAI.0000000000000604

DO - 10.1097/PAI.0000000000000604

M3 - Article

C2 - 29084054

AN - SCOPUS:85071268352

VL - 27

SP - 508

EP - 514

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 7

ER -